Champions Oncology logo
Champions Oncology CSBR
$ 4.65 8.9%

Quarterly report 2024-Q2
added 09-13-2024

report update icon

Champions Oncology Financial Ratios 2011-2024 | CSBR

Annual Financial Ratios Champions Oncology

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-9.4 -16.9 210.5 290.4 -60.0 845.2 -32.5 -3.9 -2.8 -4.4 -8.6 -2.5 -3.4 -9.1

P/S

1.4 1.7 2.3 2.6 3.7 4.0 2.4 1.7 2.6 6.5 5.5 1.9 4.1 5.0

EPS

-0.5 -0.4 0.0 0.0 -0.2 0.0 -0.1 -0.6 -1.2 -2.2 -0.1 -0.1 -0.2 -0.1

EV (Enterprise Value)

93.8 M 110 M 133 M 121 M 126 M 114 M 55.2 M 31.2 M 31.8 M 52.1 M 63.3 M 10.1 M 36.5 M 36.8 M

EBITDA per Share

-0.42 -0.23 0.16 0.1 -0.09 0.0772 -0.0903 -0.605 -1.17 -1.5 -1.08 -2.03 -2.3 -1.71

EV/EBITDA

77.0 -164.4 119.8 -47.4 -3.6 -2.6 -3.7 -9.5 -1.0 -2.7 -4.7

PEG

0.09 0.11 -1.65 -1.95 0.54 7.81 -0.42 -0.08 -0.13 0.32 -0.22 -0.51 0.04 0.82

P/B

-36.0 19.5 12.7 14.2 22.3 48.3 15991.4 67.3 121.1 7.1 19.9 2.0 -5.5 1822.0

P/CF

-11.1 22.7 17.8 -62.5 40.8 105.2 -19.5 -7.5 -4.3 -5.9 -17.3 -3.6 -5.1 -249.1

ROE %

382.34 -115.08 6.02 4.87 -38.73 5.72 -49200.00 -1721.00 -4389.08 -163.05 -231.65 -82.46 164.10 -20010.53

ROA %

-27.84 -15.55 1.55 1.31 -9.52 1.14 -18.27 -85.93 -180.82 -109.07 -83.52 -54.33 -125.12 -30.06

ROCE %

386.55 -113.37 6.67 4.93 -37.67 8.33 -216.64 -1207.27 -2190.23 -160.44 -120.20 -71.33 -263.82 -57.21

Current Ratio

0.9 1.2 1.3 1.4 1.3 1.0 0.7 0.8 0.8 2.8 2.1 3.5 1.6 3.4

DSO

63.8 59.4 61.3 52.3 52.0 59.0 70.6 53.9 42.8 43.7 41.9 21.9 29.8 58.4

DIO

- - - - - - - - - - - - - -

DPO

69.1 50.7 36.8 42.8 63.8 71.8 74.5 69.7 79.7 67.6 57.2 82.5 124.9 183.5

Operating Cycle

63.8 59.4 61.3 52.3 52.0 59.0 70.6 53.9 42.8 43.7 41.9 21.9 29.8 58.4

Cash Conversion Cycle

-5.3 8.7 24.5 9.4 -11.9 -12.8 -3.9 -15.8 -36.8 -24.0 -15.3 -60.6 -95.1 -125.1

All numbers in USD currency

Quarterly Financial Ratios Champions Oncology

2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.1 - -0.15 -0.19 - 0.06 - -0.02 - 0.07 0.02 0.01 - 0.03 - - 0.01 -0.03 0.03 0.03 -0.06 -0.01 0.02 0.02 0.04 -0.13 -0.01 -0.06 - -0.28 -0.05 -0.05 -0.26 -0.51 -0.29 -0.63 - -0.01 -0.55 -0.05 - -0.02 -0.03 -0.07 -0.03 -0.04 -0.04 -0.04 -0.03 -0.01 -0.05 -0.05 -0.04

EBITDA per Share

0.13 - -0.11 -0.16 - 0.09 0.04 0.02 - 0.09 0.05 0.06 - 0.05 0.02 0.02 0.02 -0.02 0.06 0.06 -0.04 - 0.05 0.05 0.05 -0.12 0.01 0.01 -0.05 -0.27 -0.03 -0.04 -0.25 -0.6 -0.27 -0.28 -0.33 -0.02 -0.63 -0.05 -0.05 -0.01 -0.02 - - -0.04 - -0.04 -0.03 - -0.05 -0.05 -0.06

ROE %

-4984.09 -2353.20 -2344.68 -117.97 4.80 16.66 19.99 23.60 16.68 14.40 3.90 0.49 -0.89 2.75 -14.50 0.01 14.52 -23.94 -24.15 -25.27 -26.39 90.77 37.81 -0.79 -46.72 -295.33 -333.05 -323.58 -306.92 -1208.32 -1033.58 -1079.97 -1107.26 -73.47 -154.22 73.56 -584.42 -659.25 -633.43 -780.90 -58.49 76.70 114.54 123.82 136.37 137.22 184.77 255.70 458.68 -10385.85 98.41 236.79 -10721.05

ROA %

-17.95 -13.56 -11.21 -3.94 1.37 5.17 6.62 7.61 5.12 4.49 1.19 0.25 -0.12 0.87 -3.01 -0.81 1.48 -4.57 -2.26 -1.86 -0.97 10.69 -6.91 -10.97 -15.61 -29.99 -45.08 -49.90 -54.87 -90.53 -156.17 -183.51 -202.96 -183.06 -89.14 -148.50 -176.83 -192.67 -194.79 -123.90 -91.42 -70.54 -82.32 -106.97 -123.61 -123.59 -128.00 -105.07 -86.61 -59.80 -23.79 -19.91 -16.10

ROCE %

-4738.71 -2227.27 -2218.28 -116.05 5.90 18.05 21.20 24.39 16.57 24.42 20.13 16.98 8.06 8.49 -15.29 -1.63 12.04 -23.93 -22.20 -22.16 -22.12 93.32 38.83 6.26 -31.68 -266.33 -302.70 -299.32 -290.70 -1196.04 -1008.48 -1053.88 -1080.59 -56.45 -170.34 87.74 -705.10 -785.80 -744.94 -928.90 -78.21 46.75 89.74 103.06 120.27 142.25 193.23 269.99 486.06 -11300.31 103.44 248.89 -11652.63

Current Ratio

1.0 0.9 1.0 1.1 1.2 1.4 1.3 1.4 1.4 1.5 1.4 1.4 1.4 1.3 1.4 1.3 1.3 1.3 1.2 1.1 1.2 1.1 1.2 1.1 1.0 1.4 1.1 1.1 1.1 1.5 1.7 1.7 1.0 0.4 2.2 2.5 3.0 1.8 0.6 1.1 1.6 3.5 1.6 2.3 2.9 2.2 1.3 1.8 1.7 - 2.4 2.5 2.8

DSO

60.2 - 65.7 61.6 - 62.5 58.5 62.6 52.6 49.5 2622.7 -3904.4 - 52.9 49.6 44.2 41.5 55.6 46.7 56.0 - 68.6 57.8 56.3 43.6 - 46.0 44.8 - - - - - - - - - - - - - - - - - - 2888.1 - - - - 4154.2 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

71.2 - 71.0 65.9 - 59.5 43.8 35.0 - 51.5 55.5 21.7 - 65.0 53.5 47.0 44.9 65.2 64.8 65.0 58.0 73.5 54.7 56.5 51.5 - 56.4 61.9 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

60.2 - 65.7 61.6 - 62.5 58.5 62.6 52.6 49.5 2622.7 -3904.4 - 52.9 49.6 44.2 41.5 55.6 46.7 56.0 - 68.6 57.8 56.3 43.6 - 46.0 44.8 - - - - - - - - - - - - - - - - - - 2888.1 - - - - 4154.2 -

Cash Conversion Cycle

-11.0 - -5.2 -4.3 - 3.1 14.7 27.7 52.6 -2.0 2567.2 -3926.1 - -12.1 -3.9 -2.8 -3.4 -9.6 -18.1 -9.0 -58.0 -4.8 3.0 -0.2 -7.9 - -10.4 -17.1 - - - - - - - - - - - - - - - - - - 2888.1 - - - - 4154.2 -

All numbers in USD currency